BioCircuit Technologies

BioCircuit Technologies develops advanced medical devices for peripheral nerve repair and neuromodulation, with a focus on sutureless nerve coaptation solutions. The company's flagship product, Nerve Tape®, is an FDA-cleared sutureless nerve connector device featuring integrated microscale hooks that attach to the outer nerve sheath, eliminating the need for traditional microsutures. Nerve Tape is indicated for repair of peripheral nerve discontinuities where gap closure can be achieved by extremity flexion. Clinical data demonstrates 4.8x faster repair time and 2.6x greater tensile strength compared to microsuture techniques, while distributing tension across multiple anchor points to minimize tissue damage. The device is derived from porcine biomaterial and is contraindicated in patients with known porcine sensitivity. BioCircuit also markets ConformaWrap® Nerve Protector, a complementary product for nerve protection during reconstruction. Applications include oral and maxillofacial surgery, head and neck procedures, upper and lower extremity nerve repair, and breast reconstruction with neurotization. The company serves plastic surgeons, hand surgeons, orthopedic surgeons, otolaryngologists, and reconstructive surgery specialists across US medical centers including Mayo Clinic Arizona, Weill Cornell Medicine, and RUSH University Medical Center. BioCircuit holds FDA 510(k) clearance and maintains partnerships with the NIH and Global Nerve Foundation. As of August 2025, over 3,500 Nerve Tape devices have been implanted commercially within 16 months of launch. The company was named to the 2025 Inc. 5000 list.